UBS Group Begins Coverage on Chimera Investment (NYSE:CIM)

UBS Group started coverage on shares of Chimera Investment (NYSE:CIM – Free Report) in a report issued on Wednesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $5.50 price objective on the real estate investment trust’s stock. Separately, StockNews.com assumed coverage on Chimera Investment in a research note on Thursday, October 5th. […]

Related Keywords

United States , ,Manchester Capital Management ,Allspring Global Investments Holdings ,Chimera Investment Corporation ,Worth Asset Management ,Chimera Investment Company Profile ,Ubs Group ,Wealthplan Partners ,Chimera Investment ,Free Report ,Marketbeat Ratings ,Asset Management ,Capital Management ,Global Investments Holdings ,Get Free Report ,Investment Corporation ,Chimera Investment Daily ,Nyse Cim ,Pcim ,Finance ,16934q10 ,Initiated Coverage ,Ubs Group Ag ,